Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of government agencies regarding cost-effectiveness claims: FDA perspective.

Sorry, there's nothing here.

Cite this paper

@article{Temple1999EconomicsAC, title={Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of government agencies regarding cost-effectiveness claims: FDA perspective.}, author={Robert J. Temple}, journal={American heart journal}, year={1999}, volume={137 5}, pages={S75-7} }